Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
about
CD133, Selectively Targeting the Root of CancerCo-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.Tissue biomarkers of breast cancer and their association with conventional pathologic features.Basal cell adenocarcinoma of the salivary gland: a morphological and immunohistochemical comparison with basal cell adenoma with and without capsular invasionS100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer.Di-ethylhexylphthalate (DEHP) modulates cell invasion, migration and anchorage independent growth through targeting S100P in LN-229 glioblastoma cellsS100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.A quantitative proteomics-based signature of platinum sensitivity in ovarian cancer cell lines.Imaging mass spectrometry for assessing cutaneous wound healing: analysis of pressure ulcersA meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers.Differential DNA methylation profile of key genes in malignant prostate epithelial cells transformed by inorganic arsenic or cadmiumIL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.Distinct prognostic values of S100 mRNA expression in breast cancer.Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancerCellular calcium dynamics in lactation and breast cancer: from physiology to pathology.AGEs and chronic subclinical inflammation in diabetes: disorders of immune system.S100P is Overexpressed in Squamous Cell and Adenosquamous Carcinoma Subtypes of Endometrial Cancer and Promotes Cancer Cell Proliferation and Invasion.Overexpression of S100P promotes colorectal cancer metastasis and decreases chemosensitivity to 5-FU in vitro.The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies.Plasma S100P level as a novel prognostic marker of metastatic breast cancer.Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.IQGAP Family Members in Yeast, Dictyostelium, and Mammalian Cells.Clinicopathological significance of S100 protein expression in cholangiocarcinoma.Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma.Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets.S100A16 is a prognostic marker for colorectal cancer.Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma.Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2.
P2860
Q28066353-ADAED025-0E97-4437-BC5E-47A78E51A4B8Q30624299-4B307A2C-D516-4003-84DC-99CFED239E74Q31110635-7CA899CC-BEB7-4758-8B3C-0D0BFA8107E7Q33592547-F6310A45-C17F-4109-8424-B0C5EB56A5C8Q33685170-7F4F653B-580C-43B4-8E93-C341A23A5CF7Q33742292-BD8BCC84-1D18-4DDB-85E1-E25F34DCA247Q34778723-33BB2D89-07E8-4B1D-9F4C-B94ECD50BE96Q35031170-E4C392C8-D810-45F5-B2BF-BE3844C84A8DQ35072873-1550E0D1-847C-43F7-918F-C1F9C81E4CD8Q35150412-34295C4B-291B-43ED-9248-028428A98D81Q35706402-6F3F36C3-88DF-47B4-8D6A-2530C5B62C7EQ37305013-BDBB7F27-BB33-48FE-B49B-3674BC015604Q37554595-77948784-4780-4C0E-82FF-21C057BCEA03Q37619731-E93B8FD3-BB2D-4011-89C7-0243AEA1D978Q37629032-264053C3-37F4-40F0-9CA8-F282C0E68B76Q38213275-27131291-1129-416C-9369-2DB5BB500FE0Q38727593-782F5C6D-0145-4BE2-BA2D-F491A4FA2140Q39038017-F7FBE4D0-300A-4471-99B7-4623AD94383EQ40234422-559451CE-C6D2-4E21-B8BC-DFBB7D15087CQ40768670-C5F86D7C-9BF3-4F1B-B9F6-6BCE08951AAAQ41030727-B51959AF-54E9-4CA2-B326-42D7F4990CA9Q41863287-BDA7352E-2BF3-443D-AD49-2846D812854CQ45222769-AF6BEDB6-6A01-46D6-87F3-0E6F4660DF54Q46187804-707C0D91-FC3C-4C55-A39E-CAA1D00110AFQ47243883-83E9817D-DEEB-4091-BB40-55AF48F23FADQ47849319-3BB82D6B-5D73-4566-9167-81A7B2AA0E3AQ48136210-CE7EC203-43FD-4013-8077-B7BC44688453Q50277599-EBBEDDCB-55BB-402A-86A6-1057D37C5B03Q55397325-B14AB9BC-7A56-4C55-B295-9D975FB4C2E0
P2860
Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
@en
Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
@nl
type
label
Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
@en
Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
@nl
prefLabel
Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
@en
Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
@nl
P2093
P2860
P1476
Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
@en
P2093
Haiyan Zhu
Hongfei Jiang
Qiuhong Jiang
Songying Zhang
Xiaomei Tong
P2860
P2888
P356
10.1007/S00432-011-1062-5
P577
2011-09-24T00:00:00Z